 |
Sanofi signs $335m exclusive diabetes dealSanofi-Aventis has signed an exclusive agreement on a possible new diabetes treatment with US biotech CureDM as part of the French drugmaker's aim to become a leader in the spreading disease. Sanofi could pay CureDM as m More… |
Friday 19 April 2024
